Harrow Health Inc (HROW)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark L. Baum
Employees:
134
12264 EL CAMINO REAL, SUITE 350, SAN DIEGO, CA 92130
858-704-4040

Harrow Health, Inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the United States. The company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. It also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California.

Data derived from most recent annual or quarterly report
Market Cap 268.67 Million Shares Outstanding26.894 Million Avg 30-day Volume 159.317 Thousand
P/E Ratio1225.6324 Dividend Yield0.0 EPS-0.11
Price to Revenue4.0244 Debt to Equity0.5112 EBITDA-990 Thousand
Price to Book Value7.4305 Operating Margin-9.371599999999999 Enterprise Value194.43 Million
Current Ratio2.934 EPS Growth-0.984 Quick Ratio2.215
1 Yr BETA 0.6544 52-week High/Low 12.99 / 5.13 Profit Margin-0.2443
Operating Cash Flow Growth38.2824 Altman Z-Score3.2628 Free Cash Flow to Firm -1.733 Million
View SEC Filings from HROW instead.

View recent insider trading info

Funds Holding HROW (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HROW BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LINDSTROM RICHARD L MD

  • Director
166,100 2021-09-24 4

OPALEYE MANAGEMENT INC.

  • 10% Owner
3,285,000 2021-08-19 5

BAUM MARK L CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
762,301 2021-07-23 4

BOLL ANDREW R. CHIEF FINANCIAL OFFICER

  • Officer
346,500 2021-07-23 4

SAHAREK JOHN P. PRESIDENT, IMPRIMISRX

  • Officer
277,200 2021-07-23 2

KAMMER ROBERT J

  • Director
9,644 2021-06-25 1

VAN HORN R. LAWRENCE

  • Director
9,644 2021-06-25 1

SPARKS TERESA

  • Director
9,644 2021-06-25 1

PRINCIPI ANTHONY

  • Director
93,798 2020-09-28 0

AUSTIN STEPHEN G

  • Director
91,987 2020-03-16 0

LONGBOARD CAPITAL ADVISORS, LLC

CONRAD BRETT

  • INSTITUTIONAL INVESTORMANAGING MBR OF LONGBOARD CAP.
1,416,000 2017-12-31 0

EDWARDS CLAYTON D CHIEF OPERATING OFFICER

  • Officer
0 2017-04-13 0

NELSON WILLIAM H.

  • Director
0 2016-06-10 0

MILONI DONALD PAUL

  • 10% Owner
No longer subject to file 2015-05-18 0

BASSANI AUGUST SHELBY

  • Director
13,488 2014-09-04 0

KENNY PETER C

  • Director
0 2013-10-02 0

ABRAMS JEFFREY J

  • Director
45,927 2013-06-27 0

FINNEGAN PAUL

  • Director
6,865 2013-06-27 0

SCHUPP JOACHIM PH CHIEF MEDICAL OFFICER

  • Officer
0 2013-04-01 0

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA, INC.

  • 10% Owner
832,682 2012-08-31 0

DERMASTAR INTERNATIONAL, LLC

  • 10% Owner
0 2012-06-29 0

LADONNIKOV ALEXEJ

  • 10% Owner
1,984,156 2012-02-28 0

BRAR BALBIR

  • Director
66,022 2012-01-23 0

BONFIGLIO JOHN N PRESIDENT AND CEO

  • Officer
  • Director
0 2010-10-20 0

NIDA TERRY CHIEF BUSINESS OFFICER

  • Officer
0 2010-02-26 0

LOMORO JOHN T CHIEF FINANCIAL OFFICER

  • Officer
0 2009-06-18 0

SINGH JULIET CEO, DIRECTOR AND PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2009-06-18 0

THORNLEY ANTHONY S

  • Director
0 2008-11-21 0

SWANN LYNN C

  • Director
0 2008-11-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HARROW HEALTH INC HROW 2021-11-30 17:15:03 UTC -0.6867 0.7567 600000
HARROW HEALTH INC HROW 2021-11-30 16:45:03 UTC -0.6845 0.7545 600000
HARROW HEALTH INC HROW 2021-11-30 16:15:02 UTC -0.6845 0.7545 600000
HARROW HEALTH INC HROW 2021-11-30 15:45:03 UTC -0.6845 0.7545 600000
HARROW HEALTH INC HROW 2021-11-30 15:15:04 UTC -0.6845 0.7545 600000
HARROW HEALTH INC HROW 2021-11-30 14:45:02 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-30 14:15:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-30 13:45:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-30 13:15:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-30 12:45:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 22:15:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 21:45:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 21:15:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 20:45:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 20:15:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 19:45:03 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 19:15:04 UTC -0.6432 0.7132 600000
HARROW HEALTH INC HROW 2021-11-29 18:45:03 UTC -0.6388 0.7088 600000
HARROW HEALTH INC HROW 2021-11-29 18:15:03 UTC -0.6388 0.7088 600000
HARROW HEALTH INC HROW 2021-11-29 17:45:03 UTC -0.6388 0.7088 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments